Chronic Cerebral Ischemia-Induced Memory Impairment After Inhibition of BDNF by Interleukin-1 Signaling Pathway
American Journal of Internal Medicine
Volume 5, Issue 4, July 2017, Pages: 52-56
Received: Mar. 28, 2017;
Accepted: Apr. 10, 2017;
Published: Jun. 15, 2017
Views 2101 Downloads 101
Lan Xian-wu, Department of Cardiology, The First Affiliated Hospital of Jinan University, Guangzhou, People’s Republic of China
Cui Liang, Department of Cardiology, The First Affiliated Hospital of Jinan University, Guangzhou, People’s Republic of China
Gui Wen-shan, Department of Cardiology, The First Affiliated Hospital of Jinan University, Guangzhou, People’s Republic of China
Objective To observe the abnormal expression of IL-1βin hippocampus after bilateral common carotid artery ligation and to evaluate its effects on memory impairment induced by chronic cerebral ischemia. Methods Bilateral common carotid artery ligation (2-vessel occlusion, 2VO) was performed in wild type (Wild Type WT) and interleukin -1 receptor knock-out (IL-1 Resept Knock Out, IL-1R KO) C57 mice (male) to produce chronic cerebral ischemia mouse models. After the operation, their memory was detected with eight-arm radial maze test and the novel object recognition test, and the level of IL-1β and BDNF in hippocampus was detected with Western Blot. Results The average number of working memory errors of the KO-2VO mice was significantly decreased (P<0.05), and the recognition index was significantly increased (P<0.05) compared with those of the WT-2VO mice. Dramatic decrease in IL-1β in hippocampus (P<0.05) and substantial increase in BDNF (P<0.05) were observed in the KO-2VO mice. In the behavioral experiment and Western Blot, there was no significant difference between the KO-sham mice and the WT-sham controls. Conclusion Increase in the level of the IL-1β in hippocampus after bilateral common carotid artery ligation can lead to decrease in the level of the BDNF, which may cause memory impairment.
Chronic Cerebral Ischemia-Induced Memory Impairment After Inhibition of BDNF by Interleukin-1 Signaling Pathway, American Journal of Internal Medicine.
Vol. 5, No. 4,
2017, pp. 52-56.
Sivakumar L, Camicioli R, Butcher K. Factors associated with cognitive decline in transient ischemic attack patients. Can J Neurol Sci, 2014, 41(3):303-13.
Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT. Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. Febs Journal, 2009, 276(1):13-26.
Zhou Y, Zhang J, Wang L, Chen Y, Wan Y, He Y, et al. Interleukin-1β impedes oligodendrocyte progenitor cell recruitment and white matter repair following chronic cerebral hypoperfusion. Brain Behav Immun, 2017, 60:93-105.
Leal G, Afonso PM, Salazar IL, Duarte. Regulation of hippocampal synaptic plasticity by BDNF. Brain Research, 2014, 1621:82-101.
Chen G, FU Q, Cao J, Mi W. Effect of propofol on brain-derived neurotrophic factor and tyrosine kinase receptor B in the hippocampus of aged rats with chronic cerebral ischemia. Neural Regen Res, 2012,7(21):1645-9.
Tanila H. The role of BDNF in Alzheimer's disease. Neurobiol Dis, 2017,97(Pt B):114-118.
Toyama K, Koibuchi N, Uekawa K, Hasegawa Y, Kataoka K, Katayama T, et al. Apoptosis signal regulating kinase 1 is a novel target molecule for cognitive impairment induced by chronic cerebral hypoperfusion. Arterioscler Tthromb Vvasc Biol, 2014,34( 3): 616-625.
Wang M, Norman JE, Srinivasan VJ, Rutledge JC. Metabolic, inflammatory, and microvascular determinants of white matter disease and cognitive decline. Am J Neurodegener Dis, 2016, 5(5):171-177.
Brassai A, Suvanjeiev RG, Bán EG, Lakatos M. Role of synaptic and nonsynaptic glutamate receptors in ischaemia induced neurotoxicity. Brain Res Bull, 2015, 112:1-6.
Shukla V, Shakya AK, Perez-Pinzon MA, Dave KR. Cerebral ischemic damage in diabetes: an inflammatory perspective. J Neuroinflammation, 2017,14(1):21.
Alawieh A, Elvington A, Tomlinson S. Complement in the Homeostatic and Ischemic Brain. Front Immunol, 2015,6:417.
Xiong XY, Liu L, Yang QW. Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke. Prog Neurobiol, 2016, 142:23-44.
Udeochu JC, Shea JM, Villeda SA. Microglia communication: Parallels between aging and Alzheimer's disease. Clin Exp Neuroimmunol, 2016, 7(2):114-125.
Ransohoff RM. How neuroinflammation contributes to neurodegeneration. Science, 2016, 353(6301):777-83.
Mizui T, Ishikawa Y, Kumanogoh H, Kojima M. Neurobiological actions by three distinct subtypes of brain-derived neurotrophic factor: Multi-ligand model of growth factor signaling. Pharmacol Res, 2016, 105:93-8.
Zhang ZH, Wu LN, Song JG, Li WQ. Correlations between cognitive impairment and brain?derived neurotrophic factor expression in the hippocampus of post-stroke depression rats. Mol Med Rep, 2012, 6(4):889-93.
Patterson SL. Immune dysregulation and cognitive vulnerability in the aging brain: Interactions of microglia, IL-1β, BDNF and synaptic plasticity. Neuropharmacology, 2015, 96(Pt A):11-8.